Omeprazol Stada (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Stada, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Stada is a proton‑pump inhibitor that acts on gastric acid secretion pathways: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease (PUD) associated with H. pylori infection: supports ulcer healing when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - NSAID‑induced gastropathy: reduces risk of ulcer formation. - Erosive gastritis: aids     

Common